These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. IL-1β upregulates Muc5ac expression via NF-κB-induced HIF-1α in asthma. Wu S; Li H; Yu L; Wang N; Li X; Chen W Immunol Lett; 2017 Dec; 192():20-26. PubMed ID: 29031476 [TBL] [Abstract][Full Text] [Related]
5. Targeting the NF-kappaB pathway in asthma and chronic obstructive pulmonary disease. Edwards MR; Bartlett NW; Clarke D; Birrell M; Belvisi M; Johnston SL Pharmacol Ther; 2009 Jan; 121(1):1-13. PubMed ID: 18950657 [TBL] [Abstract][Full Text] [Related]
6. The Role of Lymphocytes in the Pathogenesis of Asthma and COPD. Baraldo S; Lokar Oliani K; Turato G; Zuin R; Saetta M Curr Med Chem; 2007; 14(21):2250-6. PubMed ID: 17896974 [TBL] [Abstract][Full Text] [Related]
7. Cellular and molecular mechanisms in chronic obstructive pulmonary disease: an overview. Di Stefano A; Caramori G; Ricciardolo FL; Capelli A; Adcock IM; Donner CF Clin Exp Allergy; 2004 Aug; 34(8):1156-67. PubMed ID: 15298554 [TBL] [Abstract][Full Text] [Related]
8. The role of nuclear factor-kappaB in inflammatory lung disease. Imanifooladi AA; Yazdani S; Nourani MR Inflamm Allergy Drug Targets; 2010 Jul; 9(3):197-205. PubMed ID: 20687892 [TBL] [Abstract][Full Text] [Related]
9. Chronic obstructive pulmonary disease in a new concept. Murărescu ED; Mitrofan EC; Mihailovici MS Rom J Morphol Embryol; 2007; 48(3):207-14. PubMed ID: 17914487 [TBL] [Abstract][Full Text] [Related]
10. The role of nuclear factor kappa B in the pathogenesis of pulmonary diseases: implications for therapy. Wright JG; Christman JW Am J Respir Med; 2003; 2(3):211-9. PubMed ID: 14720003 [TBL] [Abstract][Full Text] [Related]
11. Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. Desmet C; Gosset P; Pajak B; Cataldo D; Bentires-Alj M; Lekeux P; Bureau F J Immunol; 2004 Nov; 173(9):5766-75. PubMed ID: 15494529 [TBL] [Abstract][Full Text] [Related]
12. Anti-inflammatory inhibitors of IkappaB kinase in asthma and COPD. Caramori G; Adcock IM; Ito K Curr Opin Investig Drugs; 2004 Nov; 5(11):1141-7. PubMed ID: 15573863 [TBL] [Abstract][Full Text] [Related]
14. [The function of nuclear factor-erythroid 2-related factor 2 and its association with I-kappa B kinases alpha/beta in a rat model of chronic obstructive pulmonary disease.]. Li XY; Luo BL; Chen HM Zhonghua Jie He He Hu Xi Za Zhi; 2009 Dec; 32(12):935-9. PubMed ID: 20193356 [TBL] [Abstract][Full Text] [Related]
15. Repression of inflammatory gene expression in human pulmonary epithelial cells by small-molecule IkappaB kinase inhibitors. Newton R; Holden NS; Catley MC; Oyelusi W; Leigh R; Proud D; Barnes PJ J Pharmacol Exp Ther; 2007 May; 321(2):734-42. PubMed ID: 17322026 [TBL] [Abstract][Full Text] [Related]
16. The Future of Biological Therapies in COPD. Gea J Arch Bronconeumol (Engl Ed); 2018 Apr; 54(4):185-186. PubMed ID: 29291901 [No Abstract] [Full Text] [Related]
17. Validation of the anti-inflammatory properties of small-molecule IkappaB Kinase (IKK)-2 inhibitors by comparison with adenoviral-mediated delivery of dominant-negative IKK1 and IKK2 in human airways smooth muscle. Catley MC; Sukkar MB; Chung KF; Jaffee B; Liao SM; Coyle AJ; Haddad el-B; Barnes PJ; Newton R Mol Pharmacol; 2006 Aug; 70(2):697-705. PubMed ID: 16687566 [TBL] [Abstract][Full Text] [Related]
18. IκB kinase-driven nuclear factor-κB activation in patients with asthma and chronic obstructive pulmonary disease. Gagliardo R; Chanez P; Profita M; Bonanno A; Albano GD; Montalbano AM; Pompeo F; Gagliardo C; Merendino AM; Gjomarkaj M J Allergy Clin Immunol; 2011 Sep; 128(3):635-45.e1-2. PubMed ID: 21571356 [TBL] [Abstract][Full Text] [Related]